Oppenheimer & Co’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-666
| Closed | -$24.6K | – | 1391 |
|
|
2023
Q3 | $24.6K | Sell |
666
-237
| -26% | -$8.77K | ﹤0.01% | 1362 |
|
|
2023
Q2 | $36.3K | Sell |
903
-149
| -14% | -$6K | ﹤0.01% | 1391 |
|
|
2023
Q1 | $76.3K | Sell |
1,052
-42
| -4% | -$3.05K | ﹤0.01% | 1334 |
|
|
2022
Q4 | $89.7K | Sell |
1,094
-119
| -10% | -$9.76K | ﹤0.01% | 1297 |
|
|
2022
Q3 | $115K | Sell |
1,213
-162
| -12% | -$15.4K | ﹤0.01% | 1289 |
|
|
2022
Q2 | $268K | Sell |
1,375
-66
| -5% | -$12.9K | 0.01% | 1147 |
|
|
2022
Q1 | $335K | Buy |
1,441
+37
| +3% | +$8.6K | 0.01% | 1152 |
|
|
2021
Q4 | $553K | Buy |
1,404
+6
| +0.4% | +$2.36K | 0.01% | 997 |
|
|
2021
Q3 | $625K | Buy |
1,398
+624
| +81% | +$279K | 0.01% | 925 |
|
|
2021
Q2 | $301K | Buy |
774
+23
| +3% | +$8.94K | 0.01% | 1238 |
|
|
2021
Q1 | $270K | Buy |
751
+25
| +3% | +$8.99K | 0.01% | 1225 |
|
|
2020
Q4 | $356K | Buy |
726
+43
| +6% | +$21.1K | 0.01% | 1030 |
|
|
2020
Q3 | $221K | Buy |
+683
| New | +$221K | 0.01% | 1118 |
|
|
2019
Q4 | – | Sell |
-507
| Closed | -$179K | – | 1275 |
|
|
2019
Q3 | $179K | Buy |
507
+102
| +25% | +$36K | ﹤0.01% | 1162 |
|
|
2019
Q2 | $203K | Buy |
405
+53
| +15% | +$26.6K | 0.01% | 1183 |
|
|
2019
Q1 | $350K | Buy |
352
+50
| +17% | +$49.7K | 0.01% | 966 |
|
|
2018
Q4 | $262K | Sell |
302
-2
| -0.7% | -$1.74K | 0.01% | 1000 |
|
|
2018
Q3 | $315K | Hold |
304
| – | – | 0.01% | 1047 |
|
|
2018
Q2 | $280K | Buy |
+304
| New | +$280K | 0.01% | 1085 |
|